[18F]FluorThanatrace ([18F]FTT)

DRUG2 trials

Sponsors

Abramson Cancer Center at Penn Medicine, Heather Wachtel

Conditions

Pancreatic CancerParagangliomaPheochromocytoma

Early Phase 1

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

TerminatedNCT03492164

Abramson Cancer Center at Penn MedicinePancreatic Cancer

Start: 2018-03-20End: 2024-06-11Updated: 2024-06-12

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

RecruitingNCT05636540

Heather WachtelParaganglioma, Pheochromocytoma

Start: 2023-07-01End: 2026-12-31Target: 30Updated: 2026-02-27